Unknown OBSERVATIONAL NCT05043246

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease (SIM-PBD)

Sponsor: The Second Affiliated Hospital of Chongqing Medical University

Conditions Adverse Reaction to Vaccine Covid19 Diseases, Chronic

Updated 4 times since 2021 Last updated: Aug 8, 2022 Started: Aug 1, 2021 Primary completion: May 1, 2023 Completion: Aug 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Adverse Reaction to Vaccine and Covid19 and is currently ongoing. The Second Affiliated Hospital of Chongqing Medical University leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2022 — Jul 2024 [monthly]

Recruiting
Oct 2021 — Sep 2022 [monthly]

Recruiting

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Second Affiliated Hospital of Chongqing Medical University

Data source: The Second Affiliated Hospital of Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China